President
Rolara Medaka Consulting
Fishers, Indiana
Robert L. Ternik, Ph.D., BS Pharm., is President of Rolara Medaka Consulting, LLC, focusing on drug product design and formulation development for special patient populations. Bob has over 30 years experience in the pharmaceutical industry. He has created and implemented patient centered design capability and drug product strategies for synthetic molecule drug products. Dr. Ternik has experience in formulation design and development, manufacturing process scale up and tech transfer, as well as quality systems and control strategies. Bob has led the development more than 40 pivotal clinical and commercial formulations. He has experience and expertise in oral, parenteral, and alternative dosage form development. Bob has been engaged in numerous collaborations focused on pediatric formulation development. He co-founded the IQ Consortium Drug Product Pediatric Working Group and is a former chair of the IQ Drug Product Leadership Group. He was a founding member of the Lilly Pediatric Steering Committee. Dr. Ternik remains actively engaged in both US and European based pediatric product development collaborations. Dr. Ternik represented the pharmaceutical industry on the Federal Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC).
Industrial Perspective on Recent Advances in Pediatric Formulation and Delivery Systems
Wednesday, October 25, 2023
9:00 AM – 9:30 AM ET